Privia Health Group, Inc. (PRVA) — SEC Filings

Latest SEC filings for Privia Health Group, Inc. (PRVA), explained in plain English.

Sentiment Overview: 1 bullish, 32 neutral, 1 mixed

Recent Filings (34)

• ARS Filing — ARS · 2026-04-02T08:01:31-04:00 [neutral]
• Privia Health Files Proxy Materials — DEFA14A · 2026-04-02T07:59:29-04:00 [neutral] Risk: low
  Privia Health Group, Inc. filed a DEFA14A on April 2, 2026, related to definitive proxy materials. The filing includes various graphic documents and a complete
• 8-K Filing — 8-K · 2025-12-08T00:00:00.000Z [neutral]
• Privia Health Q3 Revenue Jumps 32.5%, Net Income Doubles — 10-Q · 2025-11-06T00:00:00.000Z [mixed] Risk: medium
  Privia Health Group, Inc. (PRVA) reported robust financial performance for the three and nine months ended September 30, 2025. Revenue surged to $580.4 million
• Privia Health Group Files 8-K — 8-K · 2025-10-28T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. filed an 8-K on October 28, 2025, reporting an event that occurred on October 24, 2025. The filing is categorized under 'Other Events'
• Privia Health Group Files 8-K — 8-K · 2025-09-23T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. filed an 8-K on September 23, 2025, to report other events. The filing does not contain specific details about the nature of these eve
• Privia Health Group Files 8-K — 8-K · 2025-08-29T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. filed an 8-K on August 29, 2025, reporting an event on August 28, 2025. The filing is primarily a Regulation FD Disclosure and include
• Privia Health Posts Strong Q2 Growth, Revenue Jumps 23% — 10-Q · 2025-08-07T00:00:00.000Z [bullish] Risk: medium
  Privia Health Group, Inc. (PRVA) reported robust financial performance for the second quarter ended June 30, 2025, and the six months ended June 30, 2025. Total
• Privia Health Names New CMO, Elects Directors — 8-K · 2025-07-08T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. announced on July 3, 2025, the departure of its Chief Medical Officer, Dr. Jeffrey "Jeff" Smith, effective July 1, 2025. The company a
• Privia Health Group Files 8-K on Shareholder Vote Matters — 8-K · 2025-05-22T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. filed an 8-K on May 22, 2025, reporting on matters submitted to a vote of security holders on May 21, 2025. The filing details the com
• Privia Health Files Proxy Materials — DEFA14A · 2025-05-12T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. filed a Definitive Additional Materials (DEFA14A) on May 12, 2025. This filing relates to the company's proxy statement and indicates
• Privia Health Group Files Q1 2025 10-Q — 10-Q · 2025-05-08T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first qu
• Privia Health Group Files 2025 Proxy Statement — DEF 14A · 2025-04-04T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. filed its DEF 14A on April 4, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, including
• Privia Health Group Announces Board and Executive Compensation Changes — 8-K · 2025-03-07T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. announced on March 3, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departur
• Privia Health Group Files 2024 10-K — 10-K · 2025-02-27T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in Arlingt
• Privia Health Files 8-K — 8-K · 2025-01-13T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not cont
• SC 13G/A Filing — SC 13G/A · 2024-11-14T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-11-12T00:00:00.000Z [neutral]
• Privia Health Group Files Q3 2024 10-Q — 10-Q · 2024-11-07T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter of 2024, detailing financial performance
• Privia Health Group Files Q2 2024 10-Q — 10-Q · 2024-08-08T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter of 2024 and provides financial updates for th
• SC 13G/A Filing — SC 13G/A · 2024-07-10T00:00:00.000Z [neutral]
• Privia Health Names New Directors, Adjusts CMO Compensation — 8-K · 2024-07-03T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. announced on July 1, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new dir
• Privia Health Files 8-K for Regulatory Disclosure — 8-K · 2024-06-05T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. filed an 8-K on June 5, 2024, to disclose information under Regulation FD and to file financial statements and exhibits. The filing do
• Privia Health Group Files 8-K/A Amendment — 8-K/A · 2024-05-29T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. filed an amendment (8-K/A) on May 29, 2024, to a previous filing concerning matters submitted to a vote of security holders. The origi
• Privia Health Group Files 8-K on Shareholder Votes and Bylaws — 8-K · 2024-05-23T00:00:00.000Z [neutral] Risk: low
  Privia Health Group, Inc. filed an 8-K on May 22, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing also i
• Privia Health Group Files Q1 2024 10-Q — 10-Q · 2024-05-09T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operational updates for the first qu
• Privia Health Group DEF 14A: Executive Comp & Financials — DEF 14A · 2024-04-04T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. filed its DEF 14A on April 4, 2024, for the fiscal year ending December 31, 2023. The filing details executive compensation, including
• Privia Health Files 2023 Annual 10-K Report — 10-K · 2024-02-27T00:00:00.000Z [neutral] Risk: medium
  Privia Health Group, Inc. filed its annual 10-K report on February 27, 2024, for the fiscal year ended December 31, 2023. The filing, identified by CIK 00017596
• SC 13G Filing — SC 13G · 2024-02-13T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• FMR LLC & Abigail Johnson Hold 13.421% Stake in Privia Health — SC 13G/A · 2024-02-09T00:00:00.000Z [neutral] Risk: low
  FMR LLC, a major investment management firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Privia Health Group, Inc. (ticke
• Privia Health Reports Officer/Director Changes, Comp Arrangements — 8-K · 2024-01-29T00:00:00.000Z [neutral]
  Privia Health Group, Inc. filed an 8-K on January 29, 2024, reporting an event on January 25, 2024, related to changes in directors or officers and their compen
• BlackRock Amends Privia Health Stake, Signals Passive Investment — SC 13G/A · 2024-01-23T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 23, 2024, disclosing its ownership in Privia Health Group, Inc. as of December 31, 2023. This filing indicat
• Privia Health Files Routine 8-K for Regulation FD Disclosure — 8-K · 2024-01-08T00:00:00.000Z [neutral]
  Privia Health Group, Inc. (PRVA) filed an 8-K on January 8, 2024, to disclose information under Regulation FD and to include financial statements and exhibits.